Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 3/20 | 0.43 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.43 |
| ▸ | ACHE | P22303 | 6/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18722879 | 0.85 | NAAA (0.50) | ACHENAAAEPHX1ALDH1A1TSHR | |
| SCHEMBL19214625 | 0.84 | TSHR (0.35) | CYP4F2CYP4A11ACHEALDH1A1TSHR | |
| SCHEMBL2533277 | 0.80 | CYP4F2 (0.53) | CYP4F2CYP4A11ACHETDP1NAAA | |
| SCHEMBL2724991 | 0.80 | CYP4F2 (0.53) | CYP4F2CYP4A11ACHETDP1NAAA | |
| SCHEMBL2533990 | 0.80 | CYP4F2 (0.53) | CYP4F2CYP4A11ACHETDP1NAAA | |
| SCHEMBL23200292 | 0.79 | CYP1A2 (0.34) | — | |
| SCHEMBL22965865 | 0.79 | BLM (0.33) | ACHETDP1CA12CA1CA2 | |
| SCHEMBL21137739 | 0.79 | MEN1 (0.42) | TSHR | |
| SCHEMBL23198330 | 0.79 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL5519403 | 0.79 | CHRM1 (0.37) | ACHEGAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4428219-A2 | COMPOSITION FOR ODOUR IMPROVEMENT | Symrise AG (DE) | 2024-09-11 | — | — | EP | claimed |
| US-11332692-B2 | Composition for odour improvement | SYMRISE AG (DE) | 2022-05-17 | — | — | US | claimed |
| US-20210403830-A1 | JASMOL | SYMRISE AG (DE) | 2021-12-30 | — | — | US | claimed |
| EP-3618798-A1 | COMPOSITION FOR ODOUR IMPROVEMENT | Symrise AG (DE) | 2020-03-11 | — | — | EP | claimed |
| US-20200056118-A1 | COMPOSITION FOR ODOUR IMPROVEMENT | SYMRISE AG (DE) | 2020-02-20 | — | — | US | claimed |
| US-20260061528-A1 | FLUX COMPOSITION | HONEYWELL INTERNATIONAL INC. (US) | 2026-03-05 | — | — | US | disclosed |
| WO-2025151562-A1 | COATING COMPOSITIONS, FILMS, AND METHODS | ADEPT MATERIALS, INC. (US) | 2025-07-17 | — | — | WO | disclosed |
| EP-4428219-A3 | COMPOSITION FOR ODOUR IMPROVEMENT | Symrise AG (DE) | 2025-06-18 | — | — | EP | disclosed |
| US-20250000778-A1 | CHELANT AND CYCLODEXTRIN COMPOSITIONS | COTY INC. | 2025-01-02 | — | — | US | disclosed |
| EP-4428219-A2 | COMPOSITION FOR ODOUR IMPROVEMENT | Symrise AG (DE) | 2024-09-11 | — | — | EP | disclosed |
| EP-4428219-A2 | COMPOSITION FOR ODOUR IMPROVEMENT | Symrise AG (DE) | 2024-09-11 | — | — | EP | disclosed |
| EP-4415683-A1 | CHELANT AND CYCLODEXTRIN COMPOSITIONS | Coty Inc. (US) | 2024-08-21 | — | — | EP | disclosed |
| US-20080206173-A1 | NAIL COMPOSITIONS IN POWDERED FORM | L'OREAL (FR) | 2008-08-28 | — | — | US | disclosed |
| EP-1926577-A1 | USE OF A LATEX COMPOSITION HAVING AT LEAST ONE UREIDO FUNCTION FOR ADHERING TO WOOD | Lapeyre (FR) | 2008-06-04 | — | — | EP | disclosed |
| WO-2007026074-A1 | USE OF A LATEX COMPOSITION HAVING AT LEAST ONE UREIDO FUNCTION FOR ADHERING TO WOOD | LAPEYRE (FR) | 2007-03-08 | — | — | WO | disclosed |
| EP-1408912-B1 | TEMPERATURE INSENSITIVE ONE-PHASE MICROEMULSIONS | DOW CORNING (US) | 2007-03-07 | — | — | EP | disclosed |
| EP-1408912-A2 | TEMPERATURE INSENSITIVE ONE-PHASE MICROEMULSIONS | Dow Corning Corporation (US) | 2004-04-21 | — | — | EP | disclosed |
| WO-2003009819-A2 | TEMPERATURE INSENSITIVE ONE-PHASE MICROEMULSIONS | DOW CORNING CORPORATION (US) | 2003-02-06 | — | — | WO | disclosed |
| US-6498197-B1 | Temperature insensitive one-phase microemulsions | DOW CORNING CORPORATION | 2002-12-24 | — | — | US | disclosed |
| US-4187257-A | ESTER OF POLYEPOXIDE OR POLYESTER WITH MONOESTER OF DICARBOXYLIC ACID WITH PENTAERYTHRITOL DI- OR TRIACRYLATE | THE DOW CHEMICAL COMPANY (US) | 1980-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11332692-B2 | Composition for odour improvement | CHRM3, SGMS2, ACMSD | CYP4F2 2419/4885CYP4A11 1756/4885ACHE 1414/4885 |
| US-20200056118-A1 | COMPOSITION FOR ODOUR IMPROVEMENT | CHRM3, SGMS2, ACMSD | CYP4F2 2391/4885CYP4A11 1713/4885ACHE 1410/4885 |
| US-20080206173-A1 | NAIL COMPOSITIONS IN POWDERED FORM | NACA, PIK3C3, POLR1C | CYP4F2 1414/4885CYP4A11 1296/4885ACHE 1979/4885 |
| US-20260061528-A1 | FLUX COMPOSITION | DBF4, SPIN4, VCL | CYP4F2 442/4885CYP4A11 1661/4885ACHE 4448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.